Conditioned placebo dose reduction: A new treatment in attention-deficit hyperactivity disorder?

Journal of Developmental and Behavioral Pediatrics

Volumn 31, Issue 5, 2010, Pages 369-375

  Sandler, Adrian D ^a   Glesne, Corrine E ^a   Bodfish, James W ^b  

^a Mission Children's Hospital   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

ADHD; placebo; stimulant; treatment

Indexed keywords

AMPHETAMINE DERIVATIVE; CENTRAL STIMULANT AGENT; PLACEBO;

ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; FEMALE; HOSPITALIZATION; HUMAN; MALE; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; SEVERITY OF ILLNESS INDEX;

AMPHETAMINES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PLACEBO EFFECT; PLACEBOS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 77953869912     PISSN: 0196206X     EISSN: None     Source Type: Journal    
DOI: 10.1097/DBP.0b013e3181e121ed     Document Type: Article

References (30)

1. American Academy of Pediatrics. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108:1033-1044.
2. MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the multimodal treatment study of children with ADHD. Arch Gen Psychiatry. 1999;56:1088-1096.
3. Safer DJ, Zito JM, Fine EM. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics. 1996;98:1084-1088.
4. Whalen CK, Henker B. Stimulant pharmacotherapy for attentiondeficit/ hyperactivity disorders: an analysis of progress, problems, and prospects. In: Fisher S, Greenberg RP, eds. From Placebo to Panacea: Putting Psychiatric Drugs to the Test. New York, NY: Wiley; 1997:323-356.
5. Zametkin AJ, Ernst M. Problems in the management of ADHD. N Engl J Med. 1999;340:40-42.
6. Barkley RA, McMurray MB, Edelbrock CS, Robbins K. Side effects of methylphenidate in children with ADHD: a systemic, placebo-controlled evaluation. Pediatrics. 1990;86: 184-192.
7. American Academy of Child and Adolescent Psychiatry. Practice parameter for the use of stimulant medications in the treatment of children, adolescents and adults. J Am Acad Child Adolesc Psychiatry. 2002;41:26S- 49S.
8. Khan A, Kolts RL, Rapaport MH, Krishnan KRR, Brodhead AE, Brown WA. Magnitude of placebo response and drug-placebo differences across psychiatric disorders. Psychol Med. 2005;35:743-749.
9. Sandler AD. Placebo effects in developmental disabilities: implications for research and practice. Ment Retard Dev Disabil Res Rev. 2005;11:164-170.
10. Birmaher B, Brent DA. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 2007;46:1503-1526.
11. Swanson JM, McBurnett K, Christian DL, Wigal T. Stimulant medications and the treatment of children with ADHD. In: Ollendick TH, Prinz RJ, eds. Advances in Clinical Child Psychology. New York, NY: Plenum Press; 1995:265-322.
12. Schachar RJ, Tannock R, Cunningham C, Corkum PV. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. J Am Acad Child Adolesc Psychiatry. 1997;36:754-763.
13. Brown WA. Placebo as a treatment for depression. Neuropsychopharmacology. 1994;10:287-288.
14. Park LC, Covi L. Nonblind placebo trial: an exploration of neurotic patients' responses to placebo when its inert content is disclosed. Arch Gen Psychiatry. 1965;12:336-345.
15. Wickramasekera I. A conditioned response model of the placebo. Biofeedback Self Regul. 1980;5:5-18.
16. Ader R. The placebo effect: if it's all in your head, does that mean you only think you feel better? Adv Mind Body Med. 2000;16:7-11.
17. Ader R. Much ado about nothing. Adv Mind Body Med. 2001; 17:293-295.
18. Sandler AD, Bodfish JW. Open-label use of placebos in the treatment of ADHD: a pilot study. Child Care Health Dev. 2008; 34:104-110.
19. American Academy of Pediatrics. Clinical practice guideline: diagnosis and evaluation of the child with ADHD. Pediatrics. 2000;105:1158-1170.
20. Suchman A, Ader R. Classic conditioning and placebo effects in crossover studies. Clin Pharmacol Ther. 1992;52: 372-377.
21. Sandler AD, Glesne CE, Geller G. Children's and parents' perspectives on open-label use of placebos in the treatment of ADHD. Child Care Health Dev. 2008;34:111-120.
22. Sallee FR, McGough J, Wigal T, Donahue J, Lyne A, Biederman J; SPD503 Study Group. Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2009;48:155-165.
23. Pliszka SR, Browne RG, Olvera RL, Wynne SK. A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2000;39:619-626.
24. Mayberg HS, Silva JA, Brannan SK, et al. The functional neuroanatomy of the placebo effect. Am J Psychiatry. 2002;159: 728-737.
25. Hunter AM, Leuchter AF, Morgan ML, Cook IA. Changes in brain function (quantitative EEG concordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. Am J Psychiatry. 2006;163:1426-1432.
26. Volkow N, Wang G, Ma Y, et al. Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci. 2003;23:11461-11468.
27. Pelham WE, Hoza B, Pillow DR, et al. Effects of methylphenidate and expectancy on children with ADHD: behavior, academic performance, and attributions in a summer treatment program and regular classroom settings. J Consult Clin Psychol. 2002;70: 320-335.
28. Waschbusch DA, Pelham WE, Waxmonsky J, Johnston C. Are there placebo effects in the medication treatment of children with attention-deficit hyperactivity disorder? J Dev Behav Pediatr. 2009;30:158-168.
29. Horwitz RI, Horwitz SM. Adherence to treatment and health outcomes. Arch Intern Med. 1993;153:1863-1868.
30. Sandler AD, Bodfish JW. Placebo effects in autism: lessons from secretin. J Dev Behav Pediatr. 2000;21:347-350.